Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 2/2017

17.06.2017 | Maternal-Fetal Medicine

Mifepristone vs balloon catheter for labor induction in previous cesarean: a randomized controlled trial

verfasst von: Chanderdeep Sharma, Anjali Soni, Amit Gupta, Ashok Verma, Suresh Verma

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Objective

To compare oral mifepristone (400 mg) with trans-cervical balloon catheter for induction of labor (IOL) in post date women with previous one cesarean section (CS).

Methods

In this randomized trial, post date pregnant women (gestation 40 weeks 5 days), with previous one low segment CS (no previous vaginal delivery) were induced either with oral mifepristone (400 mg) or balloon catheter [Foley’s catheter (16 Fr); bulb filled with 30 ml normal saline]. They were re-assessed 24 and 48 h later. If at any time Bishop Score was >6; amniotomy was done, followed by oxytocin infusion. Primary outcome of the study was labor onset after first manoeuvre. Secondary outcomes were cervical ripening, need of oxytocin, vaginal delivery and CS, in two groups.

Results

From June 2012 to September 2015, we enrolled 107 women. Out of these, 57 received oral tablet mifepristone (400 mg) and 50 were inserted with balloon catheter. Labor onset after first manoeuvre was statistically significantly more in mifepristone group (37/57 vs. 13/50, respectively; p value 0.000). Bishop Score after 24 h was better in balloon catheter (p value 0.000). More women with balloon catheter required oxytocin for IOL (37/50 vs. 20/57, respectively; p value 0.000) along with higher dose [840 (320) mU vs 560 (120) mU, respectively, p value 0.000]. Failure of induction was statistically significantly higher in balloon catheter group (8 out of 50 vs. 2 out of 57, respectively, p value 0.043). There was no statistically significant difference in normal delivery or CS in either group (p value 0.242 and 0.331, respectively).

Conclusion

Oral mifepristone (400 mg) is associated with statistically significantly higher incidence of labor onset in post date pregnant women with previous one CS, as compared to balloon catheter. Both methods are primarily for cervical ripening and oxytocin should not be delayed in the absence of onset of labor.

Clinical Trial Registration

Clinical Trials Registry-India, www.​ctri.​nic.​in, CTRI/2012/05/003634.
Literatur
1.
Zurück zum Zitat Soni A, Sharma C, Verma S, Justa U, Soni PK, Verma A (2015) A prospective observational study of trial of labor after cesarean in rural India. Int J Gynaecol Obstet 129(2):156–160CrossRefPubMed Soni A, Sharma C, Verma S, Justa U, Soni PK, Verma A (2015) A prospective observational study of trial of labor after cesarean in rural India. Int J Gynaecol Obstet 129(2):156–160CrossRefPubMed
3.
Zurück zum Zitat Rossi AC, Prefumo F (2015) Pregnancy outcomes of induced labor in women with previous cesarean section: a systematic review and meta-analysis. Arch Gynecol Obstet 291(2):273–280CrossRefPubMed Rossi AC, Prefumo F (2015) Pregnancy outcomes of induced labor in women with previous cesarean section: a systematic review and meta-analysis. Arch Gynecol Obstet 291(2):273–280CrossRefPubMed
5.
Zurück zum Zitat Giacalone PL, Targosz V, Laffargue F, Boog G, Faure JM (1998) Cervical ripening with mifepristone before labor induction: a randomized study. Obstet Gynecol 92(4 Pt 1):487–492PubMed Giacalone PL, Targosz V, Laffargue F, Boog G, Faure JM (1998) Cervical ripening with mifepristone before labor induction: a randomized study. Obstet Gynecol 92(4 Pt 1):487–492PubMed
6.
Zurück zum Zitat Wing DA, Fassett MJ, Mishell DR (2000) Mifepristone for preinduction cervical ripening beyond 41 weeks’ gestation: a randomized controlled trial. Obstet Gynecol 96(4):543–548PubMed Wing DA, Fassett MJ, Mishell DR (2000) Mifepristone for preinduction cervical ripening beyond 41 weeks’ gestation: a randomized controlled trial. Obstet Gynecol 96(4):543–548PubMed
7.
Zurück zum Zitat Stenlund PM, Ekman G, Aedo AR, Bygdeman M (1999) Induction of labor with mifepristone—a randomized, double-blind study versus placebo. Acta Obstet Gynecol Scand 78(9):793–798CrossRefPubMed Stenlund PM, Ekman G, Aedo AR, Bygdeman M (1999) Induction of labor with mifepristone—a randomized, double-blind study versus placebo. Acta Obstet Gynecol Scand 78(9):793–798CrossRefPubMed
8.
Zurück zum Zitat Jozwiak M, Bloemenkamp KW, Kelly AJ, Mol BW, Irion O, Boulvain M (2012) Mechanical methods for induction of labour. Cochrane Database Syst Rev 3:CD001233 Jozwiak M, Bloemenkamp KW, Kelly AJ, Mol BW, Irion O, Boulvain M (2012) Mechanical methods for induction of labour. Cochrane Database Syst Rev 3:CD001233
9.
Zurück zum Zitat De Bonrostro Torralba C, Tejero Cabrejas EL, Marti Gamboa S, Lapresta Moros M, Campillos Maza JM, Castán MS (2017) Double-balloon catheter for induction of labour in women with a previous cesarean section, could it be the best choice? Arch Gynecol Obstet 295(5):1135–1143CrossRef De Bonrostro Torralba C, Tejero Cabrejas EL, Marti Gamboa S, Lapresta Moros M, Campillos Maza JM, Castán MS (2017) Double-balloon catheter for induction of labour in women with a previous cesarean section, could it be the best choice? Arch Gynecol Obstet 295(5):1135–1143CrossRef
10.
Zurück zum Zitat Kehl S, Weiss C, Rath W (2016) Balloon catheters for induction of labor at term after previous cesarean section: a systematic review. Eur J Obstet Gynecol Reprod Biol 204:44–50CrossRefPubMed Kehl S, Weiss C, Rath W (2016) Balloon catheters for induction of labor at term after previous cesarean section: a systematic review. Eur J Obstet Gynecol Reprod Biol 204:44–50CrossRefPubMed
11.
Zurück zum Zitat Fleming TR, DeMets DL (1993) Monitoring of clinical trials: issues and recommendations. Control Clin Trials 14(3):183–197CrossRefPubMed Fleming TR, DeMets DL (1993) Monitoring of clinical trials: issues and recommendations. Control Clin Trials 14(3):183–197CrossRefPubMed
13.
Zurück zum Zitat Pocock SJ (2005) When (not) to stop a clinical trial for benefit. JAMA 294(17):2228–2230CrossRefPubMed Pocock SJ (2005) When (not) to stop a clinical trial for benefit. JAMA 294(17):2228–2230CrossRefPubMed
14.
Zurück zum Zitat Elliott CL, Brennand JE, Calder AA (1998) The effects of mifepristone on cervical ripening and labor induction in primigravidae. Obstet Gynecol 92(5):804–809PubMed Elliott CL, Brennand JE, Calder AA (1998) The effects of mifepristone on cervical ripening and labor induction in primigravidae. Obstet Gynecol 92(5):804–809PubMed
15.
Zurück zum Zitat Frydman R, Lelaidier C, Baton C, Fernandez H, Vial M, Bouget P (1992) Labor induction in women at term with mifepristone (RU-486); a double blind, randomized, placebo controlled study. Obstet Gynecol 80:972–975PubMed Frydman R, Lelaidier C, Baton C, Fernandez H, Vial M, Bouget P (1992) Labor induction in women at term with mifepristone (RU-486); a double blind, randomized, placebo controlled study. Obstet Gynecol 80:972–975PubMed
16.
Zurück zum Zitat Rossi AC, Prefumo F (2015) Pregnancy outcomes of induced labor in women with previous cesarean section: a systematic review and meta-analysis. Arch Gynecol Obstet 291(2):273–280CrossRefPubMed Rossi AC, Prefumo F (2015) Pregnancy outcomes of induced labor in women with previous cesarean section: a systematic review and meta-analysis. Arch Gynecol Obstet 291(2):273–280CrossRefPubMed
17.
Zurück zum Zitat Giacalone PL, Daures JP, Faure JM, Boulot P, Hedon B, Laffargue F (2001) The effects of mifepristone on uterine sensitivity to oxytocin and on fetal heart rate patterns. Eur J Obstet Gynecol Reprod Biol 97:30–34CrossRefPubMed Giacalone PL, Daures JP, Faure JM, Boulot P, Hedon B, Laffargue F (2001) The effects of mifepristone on uterine sensitivity to oxytocin and on fetal heart rate patterns. Eur J Obstet Gynecol Reprod Biol 97:30–34CrossRefPubMed
18.
Zurück zum Zitat Lelaidier C, Baton C, Benifla JL, Fernandez H, Bourget P, Friedmann R (1994) Mifepristone for labor induction after previous cesarean section. Br J Obstet Gynecol 101:501–503CrossRef Lelaidier C, Baton C, Benifla JL, Fernandez H, Bourget P, Friedmann R (1994) Mifepristone for labor induction after previous cesarean section. Br J Obstet Gynecol 101:501–503CrossRef
19.
Zurück zum Zitat Su H, Li E, Weng L (1996) Mifepristone for induction of labor. Chung Hua Fu Chan Ko Tsa Chih 31:676–680PubMed Su H, Li E, Weng L (1996) Mifepristone for induction of labor. Chung Hua Fu Chan Ko Tsa Chih 31:676–680PubMed
20.
Zurück zum Zitat Berkane N, Verstraete L, Uzan S, Boog G, Maria B (2005) Use of mifepristone to ripen the cervix and induce labor in term pregnancies. Am J Obstet Gynecol 192(1):114–120CrossRefPubMed Berkane N, Verstraete L, Uzan S, Boog G, Maria B (2005) Use of mifepristone to ripen the cervix and induce labor in term pregnancies. Am J Obstet Gynecol 192(1):114–120CrossRefPubMed
21.
Zurück zum Zitat American College of Obstetricians and Gynecologists (2010) ACOG Practice bulletin no. 115: Vaginal birth after previous cesarean delivery. Obstet Gynecol 116(2 Pt 1):450–463 American College of Obstetricians and Gynecologists (2010) ACOG Practice bulletin no. 115: Vaginal birth after previous cesarean delivery. Obstet Gynecol 116(2 Pt 1):450–463
22.
Zurück zum Zitat Landon MB, Hauth JC, Leveno KJ, Spong CY, Leindecker S, Varner MW et al (2004) Maternal and perinatal outcomes associated with a trial of labor after prior cesarean delivery. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. N Engl J Med 351:2581–2589CrossRefPubMed Landon MB, Hauth JC, Leveno KJ, Spong CY, Leindecker S, Varner MW et al (2004) Maternal and perinatal outcomes associated with a trial of labor after prior cesarean delivery. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. N Engl J Med 351:2581–2589CrossRefPubMed
23.
Zurück zum Zitat Lydon-Rochelle M, Holt VL, Easterling TR, Martin DP (2001) Risk of uterine rupture during labor among women with a prior cesarean delivery. N Engl J Med 345:3–8CrossRefPubMed Lydon-Rochelle M, Holt VL, Easterling TR, Martin DP (2001) Risk of uterine rupture during labor among women with a prior cesarean delivery. N Engl J Med 345:3–8CrossRefPubMed
24.
Zurück zum Zitat Grobman WA, Gilbert S, Landon MB, Spong CY, Leveno KJ, Rouse DJ et al (2007) Outcomes of induction of labor after one prior cesarean. Obstet Gynecol 109:262–269CrossRefPubMed Grobman WA, Gilbert S, Landon MB, Spong CY, Leveno KJ, Rouse DJ et al (2007) Outcomes of induction of labor after one prior cesarean. Obstet Gynecol 109:262–269CrossRefPubMed
25.
Zurück zum Zitat Cahill AG, Waterman BM, Stamilio DM, Odibo AO, Allsworth JE, Evanoff B et al (2008) Higher maximum doses of oxytocin are associated with an unacceptably high risk for uterine rupture in patients attempting vaginal birth after cesarean delivery. Am J Obstet Gynecol 199:32(e1–e5) Cahill AG, Waterman BM, Stamilio DM, Odibo AO, Allsworth JE, Evanoff B et al (2008) Higher maximum doses of oxytocin are associated with an unacceptably high risk for uterine rupture in patients attempting vaginal birth after cesarean delivery. Am J Obstet Gynecol 199:32(e1–e5)
26.
Zurück zum Zitat Brogden RN, Goa KL, Faulds D (1993) Mifepristone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs 45(3):384–409CrossRefPubMed Brogden RN, Goa KL, Faulds D (1993) Mifepristone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs 45(3):384–409CrossRefPubMed
27.
Zurück zum Zitat Chwalisz K, Garfield RE (1998) New molecular challenges in the induction on cervical ripening. Hum Reprod 13:245–252CrossRefPubMed Chwalisz K, Garfield RE (1998) New molecular challenges in the induction on cervical ripening. Hum Reprod 13:245–252CrossRefPubMed
28.
Zurück zum Zitat Frydman R, Taylor S, Paoli C, Pourade A (1992) RU486 (mifepristone): a new tool for labor induction women at term with live fetus. Contracept Fertil Sex 20:1133–1136 Frydman R, Taylor S, Paoli C, Pourade A (1992) RU486 (mifepristone): a new tool for labor induction women at term with live fetus. Contracept Fertil Sex 20:1133–1136
Metadaten
Titel
Mifepristone vs balloon catheter for labor induction in previous cesarean: a randomized controlled trial
verfasst von
Chanderdeep Sharma
Anjali Soni
Amit Gupta
Ashok Verma
Suresh Verma
Publikationsdatum
17.06.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 2/2017
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-017-4431-8

Weitere Artikel der Ausgabe 2/2017

Archives of Gynecology and Obstetrics 2/2017 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.